Pola Kepekaan Bakteri Penyebab Ventilator Associated Pneumonia (VAP) di ICU RSUP H. Adam Malik Periode Juli-Desember 2014
Lampiran 1
DAFTAR RIWAYAT HIDUP
Nama
: Dasta Senorita Ginting
Tempat/Tanggal Lahir
: Medan/01 Desember 1994
Agama
: Kristen Protestan
Alamat
: Jalan Bunga Sedap Malam IX No.9, Medan
Riwayat Pendidikan
:1. TK Swasta Katholik Assisi (1999-2000)
2. SD Swasta St. Petrus (2000-2006)
3. SMP Negeri 1 Medan (2006-2009)
4. SMA Negeri 15 Medan (2009-2012)
5.Fakultas
Kedokteran
Universitas
Sumatera Utara (2012-sekarang)
Riwayat Pelatihan
:1. Get Together SCORE PEMA FK USU
2013
2. Seminar dan Workshop Basic Life Support
& Traumatology TBM PEMA FK USU
2013
3. Peserta Penerimaan Mahasiswa Baru
(PMB) FK USU 2012
Riwayat Organisasi
:1. UKM KMK USU
ANGGARAN BIAYA PENELITIAN
1. Persiapan Proposal
Rincian
Jumlah
Administrasi survei awal
Harga Satuan
Total
Rp 75.000,00
Rp 75.000,00
penelitian di RSUP H. Adam
Malik
Print proposal awal
50
Rp 500,00
Rp 25.000,00
Print proposal revisi
30
Rp 500,00
Rp 15.000,00
Copy dan Jilid proposal awal
5
Rp 10.500,00
Rp 52.500,00
Copy dan Jilid proposal revisi
5
Rp 7.500,00
Rp 37.500,00
Total
Rp 205.000,00
2. Taksasi Pengumpulan Data
Biaya administrasi
Rp
Rp 200.000,00
pengambilan data di RSUP H.
200.000,00
Adam Malik Medan
Total
Rp 200.000,00
3. Taksasi Analisis data dan revisi
Tinta print
1
Rp 85.000,00
Rp 85.000,00
Kertas A4
1
Rp 30.000,00
Rp 30.000,00
Copy dan Jilid KTI softcover
5
Rp
7.000,00
Rp 35.000,00
Jilid KTI hardcover
5
Rp 20.000,00
Rp 100.000,00
Total
Rp 250.000,00
4. Transportasi
Rp 200.000,00
Total Biaya Keseluruhan
Rp 855.000,00
Lampiran
Frequencies
[DataSet1] C:\Users\user\Documents\KTI Dasta 2015\Olah data\Dasta
Data.sav
Statistics
N
Valid
Missing
Mean
Median
Minimum
Maximum
Jenis
Kelamin
27
0
1.3704
1.0000
1.00
2.00
Usia
27
0
48.52
53.00
19
76
Kategori Usia
27
0
4.2963
5.0000
1.00
7.00
Bakteri
Penyebab
VAP
27
0
2.44
2.00
1
6
Frequency Table
Jenis Kelamin
Valid
laki-laki
perempuan
Total
Frequency
17
10
27
Percent
63.0
37.0
100.0
Valid Percent
63.0
37.0
100.0
Cumulative
Percent
63.0
100.0
Onset
27
0
1.30
1.00
1
2
Usia
Valid
19
20
21
30
31
35
36
40
41
43
50
53
57
58
62
64
65
67
68
70
73
76
Total
Frequency
2
1
1
1
1
1
2
1
1
1
1
1
3
1
2
1
1
1
1
1
1
1
27
Percent
7.4
3.7
3.7
3.7
3.7
3.7
7.4
3.7
3.7
3.7
3.7
3.7
11.1
3.7
7.4
3.7
3.7
3.7
3.7
3.7
3.7
3.7
100.0
Valid Percent
7.4
3.7
3.7
3.7
3.7
3.7
7.4
3.7
3.7
3.7
3.7
3.7
11.1
3.7
7.4
3.7
3.7
3.7
3.7
3.7
3.7
3.7
100.0
Cumulative
Percent
7.4
11.1
14.8
18.5
22.2
25.9
33.3
37.0
40.7
44.4
48.1
51.9
63.0
66.7
74.1
77.8
81.5
85.2
88.9
92.6
96.3
100.0
Kate gori Usia
Valid
70 tahun
Total
Frequency
2
3
5
3
5
7
2
27
Percent
7.4
11.1
18.5
11.1
18.5
25.9
7.4
100.0
Valid Percent
7.4
11.1
18.5
11.1
18.5
25.9
7.4
100.0
Cumulative
Percent
7.4
18.5
37.0
48.1
66.7
92.6
100.0
Bakteri Penyebab VAP
Valid
E. coli
Aci. baumanii
K. pneumoniae
S. maltophilia
S. aureus
Ps. aeruginosa
Total
Frequency
4
13
7
1
1
1
27
Percent
14.8
48.1
25.9
3.7
3.7
3.7
100.0
Valid Percent
14.8
48.1
25.9
3.7
3.7
3.7
100.0
Cumulative
Percent
14.8
63.0
88.9
92.6
96.3
100.0
Onset
Valid
cepat
lambat
Total
Frequency
19
8
27
Percent
70.4
29.6
100.0
Valid Percent
70.4
29.6
100.0
Cumulative
Percent
70.4
100.0
Frequencies
[DataSet6] C:\Users\user\Documents\KTI Dasta 2015\Olah data\Early
onset.sav
Bakteri Penyebab VAP
Valid
E. coli
Aci. baumanii
K. pneumoniae
Total
Frequency
4
11
4
19
Percent
21.1
57.9
21.1
100.0
Valid Percent
21.1
57.9
21.1
100.0
Cumulative
Percent
21.1
78.9
100.0
Frequencies
[DataSet1] C:\Users\user\Documents\KTI Dasta 2015\Olah data\Late
onset.sav
Bakteri Penyebab VAP
Valid
Aci. baumanii
K. pneumoniae
S. maltophilia
S. aureus
Ps. aeruginos a
Total
Frequency
2
3
1
1
1
8
Percent
25.0
37.5
12.5
12.5
12.5
100.0
Valid Percent
25.0
37.5
12.5
12.5
12.5
100.0
Cumulative
Percent
25.0
62.5
75.0
87.5
100.0
Frequency Table
[DataSet3] C:\Users\user\Documents\KTI Dasta 2015\Olah
data\Aci.baum.sav
Ampilicin
Valid
sensitif
resisten
Total
Frequency
1
12
13
Percent
7.7
92.3
100.0
Valid Percent
7.7
92.3
100.0
Cumulative
Percent
7.7
100.0
Amikacin
Valid
sensitif
resisten
Total
Frequency
6
7
13
Percent
46.2
53.8
100.0
Valid Percent
46.2
53.8
100.0
Cumulative
Percent
46.2
100.0
Ceftazidime
Valid
sensitif
resisten
Total
Frequency
2
11
13
Percent
15.4
84.6
100.0
Valid Percent
15.4
84.6
100.0
Cumulative
Percent
15.4
100.0
Ciprofloxacin
Valid
sensitif
intermediet
resisten
Total
Frequency
2
1
10
13
Percent
15.4
7.7
76.9
100.0
Valid Percent
15.4
7.7
76.9
100.0
Cumulative
Percent
15.4
23.1
100.0
Ceftriaxone
Valid
sensitif
intermediet
resisten
Total
Frequency
1
1
11
13
Percent
7.7
7.7
84.6
100.0
Valid Percent
7.7
7.7
84.6
100.0
Cumulative
Percent
7.7
15.4
100.0
Cefotaxime
Valid
sensitif
intermediet
resisten
Total
Frequency
1
1
11
13
Percent
7.7
7.7
84.6
100.0
Valid Percent
7.7
7.7
84.6
100.0
Cumulative
Percent
7.7
15.4
100.0
ESBL
Valid
Missing
Total
+
Total
System
Frequency
1
1
2
11
13
Percent
7.7
7.7
15.4
84.6
100.0
Valid Percent
50.0
50.0
100.0
Cumulative
Percent
50.0
100.0
Cefepime
Valid
sensitif
resisten
Total
Frequency
1
12
13
Percent
7.7
92.3
100.0
Valid Percent
7.7
92.3
100.0
Cumulative
Percent
7.7
100.0
Gentamicin
Valid
sensitif
resisten
Total
Frequency
3
10
13
Percent
23.1
76.9
100.0
Valid Percent
23.1
76.9
100.0
Cumulative
Percent
23.1
100.0
Levofloxacin
Valid
sensitif
intermediet
resisten
Total
Frequency
3
3
7
13
Percent
23.1
23.1
53.8
100.0
Valid Percent
23.1
23.1
53.8
100.0
Cumulative
Percent
23.1
46.2
100.0
Meropenem
Valid
sensitif
resisten
Total
Frequency
4
9
13
Percent
30.8
69.2
100.0
Valid Percent
30.8
69.2
100.0
Cumulative
Percent
30.8
100.0
Piperacillin/Tazobactam
Valid
sensitif
resisten
Total
Frequency
4
9
13
Percent
30.8
69.2
100.0
Valid Percent
30.8
69.2
100.0
Cumulative
Percent
30.8
100.0
Frequency Table
[DataSet5] C:\Users\user\Documents\KTI Dasta 2015\Olah
data\Ps.aeruginosa.sav
Amikacin
Valid
resisten
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Aztreonam
Valid
resisten
Frequency
1
Percent
100.0
Ceftazidime
Valid
resisten
Frequency
1
Percent
100.0
Ciprofloxacin
Valid
resisten
Frequency
1
Percent
100.0
Ceftriaxone
Valid
resisten
Frequency
1
Percent
100.0
Cefepime
Valid
resisten
Frequency
1
Percent
100.0
Gentamicin
Valid
resisten
Frequency
1
Percent
100.0
Meropenem
Valid
sensitif
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Ampicillin/Sulbactam
Valid
intermediet
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Trimethoprim/Sulfamethoxazole
Valid
resisten
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Tigecycline
Valid
sensitif
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Piperacillin/Tazobactam
Valid
resisten
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Frequency Table
[DataSet4] C:\Users\user\Documents\KTI Dasta 2015\Olah
data\Klebsiella pneumoniae.sav
Ampilicin
Valid
resisten
Frequency
7
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Amikacin
Valid
sensitif
resisten
Total
Frequency
6
1
7
Percent
85.7
14.3
100.0
Valid Percent
85.7
14.3
100.0
Cumulative
Percent
85.7
100.0
Aztreonam
Valid
resisten
Frequency
7
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Ceftazidime
Valid
resisten
Frequency
7
Percent
100.0
Ciprofloxacin
Valid
intermediet
resisten
Total
Frequency
1
6
7
Percent
14.3
85.7
100.0
Valid Percent
14.3
85.7
100.0
Cumulative
Percent
14.3
100.0
Ceftriaxone
Valid
resisten
Frequency
7
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Cefotaxime
Valid
resisten
Frequency
7
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Cefazolin
Valid
resisten
Frequency
7
Percent
100.0
ESBL
Valid
Missing
Total
+
System
Frequency
4
3
7
Percent
57.1
42.9
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Ertapenem
Valid
sensitif
resisten
Total
Frequency
5
2
7
Percent
71.4
28.6
100.0
Valid Percent
71.4
28.6
100.0
Cumulative
Percent
71.4
100.0
Cefepime
Valid
resisten
Frequency
7
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Gentamicin
Valid
sensitif
resisten
Total
Frequency
1
6
7
Percent
14.3
85.7
100.0
Valid Percent
14.3
85.7
100.0
Cumulative
Percent
14.3
100.0
Levofloxacin
Valid
sensitif
resisten
Total
Frequency
1
6
7
Percent
14.3
85.7
100.0
Valid Percent
14.3
85.7
100.0
Cumulative
Percent
14.3
100.0
Meropenem
Valid
sensitif
resisten
Total
Frequency
5
2
7
Percent
71.4
28.6
100.0
Valid Percent
71.4
28.6
100.0
Cumulative
Percent
71.4
100.0
Ampicillin/Sulbactam
Valid
resisten
Frequency
7
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Trimethoprim/Sulfamethoxazole
Valid
sensitif
resisten
Total
Frequency
1
6
7
Percent
14.3
85.7
100.0
Valid Percent
14.3
85.7
100.0
Cumulative
Percent
14.3
100.0
Tigecycline
Valid
sensitif
intermediet
Total
Frequency
6
1
7
Percent
85.7
14.3
100.0
Valid Percent
85.7
14.3
100.0
Cumulative
Percent
85.7
100.0
Piperacillin/Tazobactam
Valid
intermediet
resisten
Total
Frequency
3
4
7
Percent
42.9
57.1
100.0
Valid Percent
42.9
57.1
100.0
Cumulative
Percent
42.9
100.0
Frequencies
[DataSet3] C:\Users\user\Documents\KTI Dasta 2015\Olah data\E.coli
Early.sav
Ampilicin
Valid
resisten
Frequency
4
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Amikacin
Valid
sensitif
Frequency
4
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Aztreonam
Valid
sensitif
resisten
Total
Frequency
2
2
4
Percent
50.0
50.0
100.0
Valid Percent
50.0
50.0
100.0
Cumulative
Percent
50.0
100.0
Ceftazidime
Valid
sensitif
resisten
Total
Frequency
2
2
4
Percent
50.0
50.0
100.0
Valid Percent
50.0
50.0
100.0
Cumulative
Percent
50.0
100.0
Ciprofloxacin
Valid
sensitif
resisten
Total
Frequency
2
2
4
Percent
50.0
50.0
100.0
Valid Percent
50.0
50.0
100.0
Cumulative
Percent
50.0
100.0
Ceftriaxone
Valid
sensitif
resisten
Total
Frequency
1
3
4
Percent
25.0
75.0
100.0
Valid Percent
25.0
75.0
100.0
Cumulative
Percent
25.0
100.0
Cefotaxime
Valid
sensitif
resisten
Total
Frequency
1
3
4
Percent
25.0
75.0
100.0
Valid Percent
25.0
75.0
100.0
Cumulative
Percent
25.0
100.0
Cefazolin
Valid
sensitif
resisten
Total
Frequency
1
3
4
Percent
25.0
75.0
100.0
Valid Percent
25.0
75.0
100.0
Cumulative
Percent
25.0
100.0
ESBL
Valid
+
Total
Frequency
2
2
4
Percent
50.0
50.0
100.0
Valid Percent
50.0
50.0
100.0
Cumulative
Percent
50.0
100.0
Cefepime
Valid
sensitif
resisten
Total
Frequency
2
2
4
Percent
50.0
50.0
100.0
Valid Percent
50.0
50.0
100.0
Cumulative
Percent
50.0
100.0
Gentamicin
Valid
sensitif
resisten
Total
Frequency
2
2
4
Percent
50.0
50.0
100.0
Valid Percent
50.0
50.0
100.0
Cumulative
Percent
50.0
100.0
Levofloxacin
Valid
Frequency
2
2
4
sensitif
resisten
Total
Percent
50.0
50.0
100.0
Cumulative
Percent
50.0
100.0
Valid Percent
50.0
50.0
100.0
Meropenem
Valid
Frequency
3
1
4
sensitif
resisten
Total
Percent
75.0
25.0
100.0
Cumulative
Percent
75.0
100.0
Valid Percent
75.0
25.0
100.0
Ampicillin/Sulbactam
Valid
Frequency
2
2
4
sensitif
resisten
Total
Percent
50.0
50.0
100.0
Cumulative
Percent
50.0
100.0
Valid Percent
50.0
50.0
100.0
Trimethoprim/Sulfamethoxazole
Valid
sensitif
Frequency
4
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Tigecycline
Valid
sensitif
Frequency
4
Percent
100.0
Piperacillin/Tazobactam
Valid
sensitif
intermediet
resisten
Total
Frequency
2
1
1
4
Percent
50.0
25.0
25.0
100.0
Valid Percent
50.0
25.0
25.0
100.0
Cumulative
Percent
50.0
75.0
100.0
Frequencies
[DataSet7] C:\Users\user\Documents\KTI Dasta 2015\Olah
data\S.maltoph.sav
Ampilicin
Valid
resisten
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Amikacin
Valid
resisten
Frequency
1
Percent
100.0
Aztreonam
Valid
resisten
Frequency
1
Percent
100.0
Ceftazidime
Valid
resisten
Frequency
1
Percent
100.0
Ciprofloxacin
Valid
resisten
Frequency
1
Percent
100.0
Ceftriaxone
Valid
resisten
Frequency
1
Percent
100.0
Cefepime
Valid
Frequency
1
resisten
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Gentamicin
Valid
Frequency
1
resisten
Percent
100.0
Levofloxacin
Valid
intermediet
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Meropenem
Valid
resisten
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Ampicillin/Sulbactam
Valid
resisten
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Trimethoprim/Sulfamethoxazole
Valid
resisten
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Tigecycline
Valid
sensitif
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Piperacillin/Tazobactam
Valid
resisten
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Frequencies
[DataSet8] C:\Users\user\Documents\KTI Dasta 2015\Olah
data\S.aureus.sav
Ampilicin
Valid
resisten
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Amoxicillin
Valid
resisten
Frequency
1
Percent
100.0
Amikacin
Valid
sensitif
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Aztreonam
Valid
sensitif
Frequency
1
Percent
100.0
Ceftazidime
Valid
sensitif
Frequency
1
Percent
100.0
Ciprofloxacin
Valid
resisten
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Cefmetazole
Valid
sensitif
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Ceftriaxone
Valid
sensitif
Frequency
1
Percent
100.0
Cefotaxime
Valid
sensitif
Frequency
1
Percent
100.0
ESBL
Valid
-
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Ertapenem
Valid
sensitif
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Cefepime
Valid
sensitif
Frequency
1
Percent
100.0
Gentamicin
Valid
sensitif
Frequency
1
Percent
100.0
Levofloxacin
Valid
Frequency
1
resisten
Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Meropenem
Valid
sensitif
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Ampicillin/Sulbactam
Valid
intermediet
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Trimethoprim/Sulfamethoxazole
Valid
resisten
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Tigecycline
Valid
sensitif
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Piperacillin/Tazobactam
Valid
sensitif
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Patient
ID
Testing Date
Organism Name
Onset
AM
Esch.coli
E
R
AMC
AMX
AN
ATM
CAZ
CIP
CRO
CTX
CZ
R
S
R
R
R
R
R
R
R
R
R
R
R
S
R
R
R
R
R
R
R
R
R
S
R
R
R
R
DOR
ESB
ETP
FEP
GM
+
S
R
+
S
IPM
LEV
MEM
SAM
SXT
TGC
TZP
R
R
S
R
S
S
I
R
R
I
R
R
R
S
R
R
R
R
S
R
R
S
I
R
R
I
R
R
R
S
R
R
S
R
S
R
R
S
R
609028
8/2/2014
610522
9/23/2014
Aci.baumannii
E
R
616020
8/15/2014
K.pneum.pneumoniae
E
R
616608
8/13/2014
Aci.baumannii
E
R
617840
8/13/2014
K.pneum.pneumoniae
E
R
595190
11/11/2014
K.pneum.pneumoniae
L
R
S
R
R
R
R
R
R
R
R
R
R
S
I
R
606159
12/1/2014
Steno.maltophilia
L
R
R
R
R
R
R
R
R
R
I
R
R
R
S
R
609469
12/30/2014
Staph.aureus
L
R
S
S
S
R
S
S
S
R
S
I
R
S
S
611338
8/6/2014
Aci.baumannii
L
R
R
R
R
R
R
R
R
I
R
R
R
S
R
611696
9/17/2014
Aci.baumannii
E
R
S
R
R
I
R
R
R
S
S
R
R
S
S
611936
9/24/2014
Aci.baumannii
E
S
S
I
S
S
S
S
S
S
S
S
S
S
S
S
618956
8/6/2014
K.pneum.pneumoniae
E
R
R
R
R
R
R
R
R
R
R
R
R
S
R
619931
10/16/2014
Esch.coli
E
R
S
R
R
R
R
R
R
R
R
R
S
S
R
622877
7/16/2014
Aci.baumannii
E
R
R
S
R
R
R
S
R
S
R
S
S
623746
10/17/2014
Esch.coli
E
R
R
S
S
R
R
S
S
S
S
S
S
624873
11/19/2014
Aci.baumannii
L
R
R
R
R
R
625344
12/2/2014
Esch.coli
E
R
R
S
S
S
S
S
628059
9/13/2014
Aci.baumannii
E
R
R
S
S
S
606356
10/2/2014
Aci.baumannii
E
R
615868
7/2/2014
K.pneum.pneumoniae
E
R
616055
11/7/2014
Aci.baumannii
E
620319
9/12/2014
Ps.aeruginosa
617163
9/13/2014
610851
R
R
R
R
R
S
R
R
R
R
R
R
R
R
S
S
S
S
S
I
I
R
R
S
R
R
I
R
R
R
R
R
R
R
L
I
R
R
R
R
R
Aci.baumannii
E
R
S
R
R
R
R
12/1/2014
Aci.baumannii
E
R
S
R
R
R
R
619455
10/22/2014
Aci.baumannii
E
R
R
R
R
R
R
611712
8/4/2014
K.pneum.pneumoniae
L
R
S
R
R
R
R
R
623582
7/4/2014
K.pneum.pneumoniae
L
R
R
R
R
S
R
R
R
R
-
R
S
R
+
S
S
R
R
R
R
S
R
R
R
+
R
S
R
S
S
R
R
R
S
S
S
S
R
S
S
S
S
R
R
R
R
R
R
S
R
R
R
S
S
R
R
S
I
R
R
R
R
R
R
S
R
R
R
R
S
I
R
S
R
R
S
R
R
S
R
S
R
R
R
R
R
R
R
R
S
R
R
R
R
R
R
R
S
R
R
R
R
S
R
R
S
I
R
S
R
+
R
-
R
+
S
S
R
S
R
S
S
ffi
PAI{DIIIIKAN
I}A1S T{T'BUNAYA AN
UI{IVERSITASSI]I\IATERA{ITARA
FAITULTAS KEDOKTfiRAN
20155
F
Jalan dr. T. Mansur No. 5 Kampus USU Medan
Telp, (061) 8211445,8210555 Fax. (061) 8216264, e-mail: dean.med@usu.ac.id
, V71 /uN5.2.1. r/sPB/2ol
No
Lamp
Hal
: Izin Penelitian
Medan, ?{Agustus 2015
5
Kepada Yth:
Direktur RS{-IP F.{aji Adann Malik Medan
di
Tempat
Dengan horrnat, berkenaan derlgan kegiatan Kryya Tulis llmiah (KTI) Mahasiswa Falrultas
Kedokteran USU Angkatan 20l2,maka karni mohon kepada Mahasiswa tersebut di bawah
ini:
NamA
NIM
JUDUL
: DASTA SENORITA GINTING
: tr20tr00251
: Pola Kepekaan Bakteri Fenyebab Ventilatory Associated Pneumonia
(VAP) di ICU RSttP H. Adam Malik Periode Juli-Desernber 2014
Dapat diberi izin Peneli,tian di Institusi yang Bapakltbu Pimpin, dalam rangka pengunrpulan
data untuk penulisan
KTI
tersebut.
''"*'
Demikian Atas bantuan dan perhatian mengenai hal ini kami ucapkan terima kasih.
N]F. 195
Tembusan:
- Pertinggal
D.Tjrpta, SpA(K)
v 198111 I 002
rqf,e*
Hft * HfirrnrffiE|r kt
ffi 3ft eH* Hffi
tL
20lE[ - lmilonsia
ll, Br. tamlur to S tdan,
Tel: +62414.21{045; 8210555 Fax: +62€14218264 E-mail:
komisieti kfkusu@ya haoo.com
PERSETUJUAII KOMISI ETIK TENTANG
PELAKSANAAIT PENELITIAI\ BIDANG KESEHATAN
Namor: 196IKOMET IFK USU /2015
Yang bertanda tangan di bawah ini, Ketua Komisi Etik Penelitian Bidang Kesehatan Fakultas
Kedokteran Universitas Sumatera Utara, setelah dilaksanakan pembahasan dan penilaian usulan
penelitian yang berjudul :
"Pola Kepekaan Bakteri Penyebab Ventilator AssociatedPneumonia {VAP)
Di ICU RSUP H. Adam Malik Periode Juli-Desember 2014',
Yang menggunakan manusia d*==+er*,m sebagai subjek penelitian dengan
Pelaksana/Peneliti Utama: Dasta Senorita
ketua
Ginting
Dari Institusi : Fakultas Kedokteran USU
Dapat disetujui pelaksanaannya selama tidak bertentangan dengan kaidah neuremberg code dan
deklarasi helsinki.
Medan, 4Q- Agustus 2015
Komisi Etik Penelitian Bidang Kesehatan
:
RSUP H.ADAl\d MALIK
DIREKTORAT SDM DAN PENDIDIKAN
INSTALASI PENELITIAN DAN PENGEMBANGAN
Jl. Bunga LauNo. 17 Medan
L8.02.03.II.4
Nomor.
"
*"*
iffitr-ffir?
Pos247 Airphone 142
lln
Medan, O( September 2015
Lampiran
Ijin Penelitian
Perihal
Yth
Kepada
:
.&.*r. ..n!M.B.e,qv^. &e*erv
rrd/;
RSUP H Adam Malik
di-
Medan
Medan
Menindaklanjuti surat pembantu Dekan I Fakultas Kedokteran Universitas Sumatera Utara
No.77gluN5.2.1.l/SpB ll2}ll,Tanggal24Agustus 2015 perihal : Ijin Penelitian, maka bersama ini
kami hadapkan peneliti/Ivlahasiswa tersebut untuk dibantu dalam pelaksanaannyavA.dapun nama
penelitiltvlahasiswa yang akan melaksanakan sebagai berikut
NaMA
:DASTASENORITAGINTING
NIM
:
Institusi
: FK-USU Medan
Judu
1
:
120100251
: Pola Kepekaan Bakteri Penyebab Ventilator Associated Pneumonia (VAP) di ICU
RSUP H. Adam Malik Medan Periode'Januari
perlu kami informasikan surat
iiin
penelitian
ini
-
Desember 2014
berlangsung paling lambat 1 (satu) bulan
terhitung sejak surat ini dikeluarkan.
Demikian kami sarnpaikan, atas perhati{lnnya diucapkan terimakasih.
Kepala Instalasi Litbang,
[A
line *diLtuti,sKM.M.Kes
NrP.197106181995
Tembusan
:
l.Ka.Bidang Diklit RSUP H Adam Malik Medan
0l
2001
DAFTAR RIWAYAT HIDUP
Nama
: Dasta Senorita Ginting
Tempat/Tanggal Lahir
: Medan/01 Desember 1994
Agama
: Kristen Protestan
Alamat
: Jalan Bunga Sedap Malam IX No.9, Medan
Riwayat Pendidikan
:1. TK Swasta Katholik Assisi (1999-2000)
2. SD Swasta St. Petrus (2000-2006)
3. SMP Negeri 1 Medan (2006-2009)
4. SMA Negeri 15 Medan (2009-2012)
5.Fakultas
Kedokteran
Universitas
Sumatera Utara (2012-sekarang)
Riwayat Pelatihan
:1. Get Together SCORE PEMA FK USU
2013
2. Seminar dan Workshop Basic Life Support
& Traumatology TBM PEMA FK USU
2013
3. Peserta Penerimaan Mahasiswa Baru
(PMB) FK USU 2012
Riwayat Organisasi
:1. UKM KMK USU
ANGGARAN BIAYA PENELITIAN
1. Persiapan Proposal
Rincian
Jumlah
Administrasi survei awal
Harga Satuan
Total
Rp 75.000,00
Rp 75.000,00
penelitian di RSUP H. Adam
Malik
Print proposal awal
50
Rp 500,00
Rp 25.000,00
Print proposal revisi
30
Rp 500,00
Rp 15.000,00
Copy dan Jilid proposal awal
5
Rp 10.500,00
Rp 52.500,00
Copy dan Jilid proposal revisi
5
Rp 7.500,00
Rp 37.500,00
Total
Rp 205.000,00
2. Taksasi Pengumpulan Data
Biaya administrasi
Rp
Rp 200.000,00
pengambilan data di RSUP H.
200.000,00
Adam Malik Medan
Total
Rp 200.000,00
3. Taksasi Analisis data dan revisi
Tinta print
1
Rp 85.000,00
Rp 85.000,00
Kertas A4
1
Rp 30.000,00
Rp 30.000,00
Copy dan Jilid KTI softcover
5
Rp
7.000,00
Rp 35.000,00
Jilid KTI hardcover
5
Rp 20.000,00
Rp 100.000,00
Total
Rp 250.000,00
4. Transportasi
Rp 200.000,00
Total Biaya Keseluruhan
Rp 855.000,00
Lampiran
Frequencies
[DataSet1] C:\Users\user\Documents\KTI Dasta 2015\Olah data\Dasta
Data.sav
Statistics
N
Valid
Missing
Mean
Median
Minimum
Maximum
Jenis
Kelamin
27
0
1.3704
1.0000
1.00
2.00
Usia
27
0
48.52
53.00
19
76
Kategori Usia
27
0
4.2963
5.0000
1.00
7.00
Bakteri
Penyebab
VAP
27
0
2.44
2.00
1
6
Frequency Table
Jenis Kelamin
Valid
laki-laki
perempuan
Total
Frequency
17
10
27
Percent
63.0
37.0
100.0
Valid Percent
63.0
37.0
100.0
Cumulative
Percent
63.0
100.0
Onset
27
0
1.30
1.00
1
2
Usia
Valid
19
20
21
30
31
35
36
40
41
43
50
53
57
58
62
64
65
67
68
70
73
76
Total
Frequency
2
1
1
1
1
1
2
1
1
1
1
1
3
1
2
1
1
1
1
1
1
1
27
Percent
7.4
3.7
3.7
3.7
3.7
3.7
7.4
3.7
3.7
3.7
3.7
3.7
11.1
3.7
7.4
3.7
3.7
3.7
3.7
3.7
3.7
3.7
100.0
Valid Percent
7.4
3.7
3.7
3.7
3.7
3.7
7.4
3.7
3.7
3.7
3.7
3.7
11.1
3.7
7.4
3.7
3.7
3.7
3.7
3.7
3.7
3.7
100.0
Cumulative
Percent
7.4
11.1
14.8
18.5
22.2
25.9
33.3
37.0
40.7
44.4
48.1
51.9
63.0
66.7
74.1
77.8
81.5
85.2
88.9
92.6
96.3
100.0
Kate gori Usia
Valid
70 tahun
Total
Frequency
2
3
5
3
5
7
2
27
Percent
7.4
11.1
18.5
11.1
18.5
25.9
7.4
100.0
Valid Percent
7.4
11.1
18.5
11.1
18.5
25.9
7.4
100.0
Cumulative
Percent
7.4
18.5
37.0
48.1
66.7
92.6
100.0
Bakteri Penyebab VAP
Valid
E. coli
Aci. baumanii
K. pneumoniae
S. maltophilia
S. aureus
Ps. aeruginosa
Total
Frequency
4
13
7
1
1
1
27
Percent
14.8
48.1
25.9
3.7
3.7
3.7
100.0
Valid Percent
14.8
48.1
25.9
3.7
3.7
3.7
100.0
Cumulative
Percent
14.8
63.0
88.9
92.6
96.3
100.0
Onset
Valid
cepat
lambat
Total
Frequency
19
8
27
Percent
70.4
29.6
100.0
Valid Percent
70.4
29.6
100.0
Cumulative
Percent
70.4
100.0
Frequencies
[DataSet6] C:\Users\user\Documents\KTI Dasta 2015\Olah data\Early
onset.sav
Bakteri Penyebab VAP
Valid
E. coli
Aci. baumanii
K. pneumoniae
Total
Frequency
4
11
4
19
Percent
21.1
57.9
21.1
100.0
Valid Percent
21.1
57.9
21.1
100.0
Cumulative
Percent
21.1
78.9
100.0
Frequencies
[DataSet1] C:\Users\user\Documents\KTI Dasta 2015\Olah data\Late
onset.sav
Bakteri Penyebab VAP
Valid
Aci. baumanii
K. pneumoniae
S. maltophilia
S. aureus
Ps. aeruginos a
Total
Frequency
2
3
1
1
1
8
Percent
25.0
37.5
12.5
12.5
12.5
100.0
Valid Percent
25.0
37.5
12.5
12.5
12.5
100.0
Cumulative
Percent
25.0
62.5
75.0
87.5
100.0
Frequency Table
[DataSet3] C:\Users\user\Documents\KTI Dasta 2015\Olah
data\Aci.baum.sav
Ampilicin
Valid
sensitif
resisten
Total
Frequency
1
12
13
Percent
7.7
92.3
100.0
Valid Percent
7.7
92.3
100.0
Cumulative
Percent
7.7
100.0
Amikacin
Valid
sensitif
resisten
Total
Frequency
6
7
13
Percent
46.2
53.8
100.0
Valid Percent
46.2
53.8
100.0
Cumulative
Percent
46.2
100.0
Ceftazidime
Valid
sensitif
resisten
Total
Frequency
2
11
13
Percent
15.4
84.6
100.0
Valid Percent
15.4
84.6
100.0
Cumulative
Percent
15.4
100.0
Ciprofloxacin
Valid
sensitif
intermediet
resisten
Total
Frequency
2
1
10
13
Percent
15.4
7.7
76.9
100.0
Valid Percent
15.4
7.7
76.9
100.0
Cumulative
Percent
15.4
23.1
100.0
Ceftriaxone
Valid
sensitif
intermediet
resisten
Total
Frequency
1
1
11
13
Percent
7.7
7.7
84.6
100.0
Valid Percent
7.7
7.7
84.6
100.0
Cumulative
Percent
7.7
15.4
100.0
Cefotaxime
Valid
sensitif
intermediet
resisten
Total
Frequency
1
1
11
13
Percent
7.7
7.7
84.6
100.0
Valid Percent
7.7
7.7
84.6
100.0
Cumulative
Percent
7.7
15.4
100.0
ESBL
Valid
Missing
Total
+
Total
System
Frequency
1
1
2
11
13
Percent
7.7
7.7
15.4
84.6
100.0
Valid Percent
50.0
50.0
100.0
Cumulative
Percent
50.0
100.0
Cefepime
Valid
sensitif
resisten
Total
Frequency
1
12
13
Percent
7.7
92.3
100.0
Valid Percent
7.7
92.3
100.0
Cumulative
Percent
7.7
100.0
Gentamicin
Valid
sensitif
resisten
Total
Frequency
3
10
13
Percent
23.1
76.9
100.0
Valid Percent
23.1
76.9
100.0
Cumulative
Percent
23.1
100.0
Levofloxacin
Valid
sensitif
intermediet
resisten
Total
Frequency
3
3
7
13
Percent
23.1
23.1
53.8
100.0
Valid Percent
23.1
23.1
53.8
100.0
Cumulative
Percent
23.1
46.2
100.0
Meropenem
Valid
sensitif
resisten
Total
Frequency
4
9
13
Percent
30.8
69.2
100.0
Valid Percent
30.8
69.2
100.0
Cumulative
Percent
30.8
100.0
Piperacillin/Tazobactam
Valid
sensitif
resisten
Total
Frequency
4
9
13
Percent
30.8
69.2
100.0
Valid Percent
30.8
69.2
100.0
Cumulative
Percent
30.8
100.0
Frequency Table
[DataSet5] C:\Users\user\Documents\KTI Dasta 2015\Olah
data\Ps.aeruginosa.sav
Amikacin
Valid
resisten
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Aztreonam
Valid
resisten
Frequency
1
Percent
100.0
Ceftazidime
Valid
resisten
Frequency
1
Percent
100.0
Ciprofloxacin
Valid
resisten
Frequency
1
Percent
100.0
Ceftriaxone
Valid
resisten
Frequency
1
Percent
100.0
Cefepime
Valid
resisten
Frequency
1
Percent
100.0
Gentamicin
Valid
resisten
Frequency
1
Percent
100.0
Meropenem
Valid
sensitif
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Ampicillin/Sulbactam
Valid
intermediet
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Trimethoprim/Sulfamethoxazole
Valid
resisten
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Tigecycline
Valid
sensitif
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Piperacillin/Tazobactam
Valid
resisten
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Frequency Table
[DataSet4] C:\Users\user\Documents\KTI Dasta 2015\Olah
data\Klebsiella pneumoniae.sav
Ampilicin
Valid
resisten
Frequency
7
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Amikacin
Valid
sensitif
resisten
Total
Frequency
6
1
7
Percent
85.7
14.3
100.0
Valid Percent
85.7
14.3
100.0
Cumulative
Percent
85.7
100.0
Aztreonam
Valid
resisten
Frequency
7
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Ceftazidime
Valid
resisten
Frequency
7
Percent
100.0
Ciprofloxacin
Valid
intermediet
resisten
Total
Frequency
1
6
7
Percent
14.3
85.7
100.0
Valid Percent
14.3
85.7
100.0
Cumulative
Percent
14.3
100.0
Ceftriaxone
Valid
resisten
Frequency
7
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Cefotaxime
Valid
resisten
Frequency
7
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Cefazolin
Valid
resisten
Frequency
7
Percent
100.0
ESBL
Valid
Missing
Total
+
System
Frequency
4
3
7
Percent
57.1
42.9
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Ertapenem
Valid
sensitif
resisten
Total
Frequency
5
2
7
Percent
71.4
28.6
100.0
Valid Percent
71.4
28.6
100.0
Cumulative
Percent
71.4
100.0
Cefepime
Valid
resisten
Frequency
7
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Gentamicin
Valid
sensitif
resisten
Total
Frequency
1
6
7
Percent
14.3
85.7
100.0
Valid Percent
14.3
85.7
100.0
Cumulative
Percent
14.3
100.0
Levofloxacin
Valid
sensitif
resisten
Total
Frequency
1
6
7
Percent
14.3
85.7
100.0
Valid Percent
14.3
85.7
100.0
Cumulative
Percent
14.3
100.0
Meropenem
Valid
sensitif
resisten
Total
Frequency
5
2
7
Percent
71.4
28.6
100.0
Valid Percent
71.4
28.6
100.0
Cumulative
Percent
71.4
100.0
Ampicillin/Sulbactam
Valid
resisten
Frequency
7
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Trimethoprim/Sulfamethoxazole
Valid
sensitif
resisten
Total
Frequency
1
6
7
Percent
14.3
85.7
100.0
Valid Percent
14.3
85.7
100.0
Cumulative
Percent
14.3
100.0
Tigecycline
Valid
sensitif
intermediet
Total
Frequency
6
1
7
Percent
85.7
14.3
100.0
Valid Percent
85.7
14.3
100.0
Cumulative
Percent
85.7
100.0
Piperacillin/Tazobactam
Valid
intermediet
resisten
Total
Frequency
3
4
7
Percent
42.9
57.1
100.0
Valid Percent
42.9
57.1
100.0
Cumulative
Percent
42.9
100.0
Frequencies
[DataSet3] C:\Users\user\Documents\KTI Dasta 2015\Olah data\E.coli
Early.sav
Ampilicin
Valid
resisten
Frequency
4
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Amikacin
Valid
sensitif
Frequency
4
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Aztreonam
Valid
sensitif
resisten
Total
Frequency
2
2
4
Percent
50.0
50.0
100.0
Valid Percent
50.0
50.0
100.0
Cumulative
Percent
50.0
100.0
Ceftazidime
Valid
sensitif
resisten
Total
Frequency
2
2
4
Percent
50.0
50.0
100.0
Valid Percent
50.0
50.0
100.0
Cumulative
Percent
50.0
100.0
Ciprofloxacin
Valid
sensitif
resisten
Total
Frequency
2
2
4
Percent
50.0
50.0
100.0
Valid Percent
50.0
50.0
100.0
Cumulative
Percent
50.0
100.0
Ceftriaxone
Valid
sensitif
resisten
Total
Frequency
1
3
4
Percent
25.0
75.0
100.0
Valid Percent
25.0
75.0
100.0
Cumulative
Percent
25.0
100.0
Cefotaxime
Valid
sensitif
resisten
Total
Frequency
1
3
4
Percent
25.0
75.0
100.0
Valid Percent
25.0
75.0
100.0
Cumulative
Percent
25.0
100.0
Cefazolin
Valid
sensitif
resisten
Total
Frequency
1
3
4
Percent
25.0
75.0
100.0
Valid Percent
25.0
75.0
100.0
Cumulative
Percent
25.0
100.0
ESBL
Valid
+
Total
Frequency
2
2
4
Percent
50.0
50.0
100.0
Valid Percent
50.0
50.0
100.0
Cumulative
Percent
50.0
100.0
Cefepime
Valid
sensitif
resisten
Total
Frequency
2
2
4
Percent
50.0
50.0
100.0
Valid Percent
50.0
50.0
100.0
Cumulative
Percent
50.0
100.0
Gentamicin
Valid
sensitif
resisten
Total
Frequency
2
2
4
Percent
50.0
50.0
100.0
Valid Percent
50.0
50.0
100.0
Cumulative
Percent
50.0
100.0
Levofloxacin
Valid
Frequency
2
2
4
sensitif
resisten
Total
Percent
50.0
50.0
100.0
Cumulative
Percent
50.0
100.0
Valid Percent
50.0
50.0
100.0
Meropenem
Valid
Frequency
3
1
4
sensitif
resisten
Total
Percent
75.0
25.0
100.0
Cumulative
Percent
75.0
100.0
Valid Percent
75.0
25.0
100.0
Ampicillin/Sulbactam
Valid
Frequency
2
2
4
sensitif
resisten
Total
Percent
50.0
50.0
100.0
Cumulative
Percent
50.0
100.0
Valid Percent
50.0
50.0
100.0
Trimethoprim/Sulfamethoxazole
Valid
sensitif
Frequency
4
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Tigecycline
Valid
sensitif
Frequency
4
Percent
100.0
Piperacillin/Tazobactam
Valid
sensitif
intermediet
resisten
Total
Frequency
2
1
1
4
Percent
50.0
25.0
25.0
100.0
Valid Percent
50.0
25.0
25.0
100.0
Cumulative
Percent
50.0
75.0
100.0
Frequencies
[DataSet7] C:\Users\user\Documents\KTI Dasta 2015\Olah
data\S.maltoph.sav
Ampilicin
Valid
resisten
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Amikacin
Valid
resisten
Frequency
1
Percent
100.0
Aztreonam
Valid
resisten
Frequency
1
Percent
100.0
Ceftazidime
Valid
resisten
Frequency
1
Percent
100.0
Ciprofloxacin
Valid
resisten
Frequency
1
Percent
100.0
Ceftriaxone
Valid
resisten
Frequency
1
Percent
100.0
Cefepime
Valid
Frequency
1
resisten
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Gentamicin
Valid
Frequency
1
resisten
Percent
100.0
Levofloxacin
Valid
intermediet
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Meropenem
Valid
resisten
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Ampicillin/Sulbactam
Valid
resisten
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Trimethoprim/Sulfamethoxazole
Valid
resisten
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Tigecycline
Valid
sensitif
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Piperacillin/Tazobactam
Valid
resisten
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Frequencies
[DataSet8] C:\Users\user\Documents\KTI Dasta 2015\Olah
data\S.aureus.sav
Ampilicin
Valid
resisten
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Amoxicillin
Valid
resisten
Frequency
1
Percent
100.0
Amikacin
Valid
sensitif
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Aztreonam
Valid
sensitif
Frequency
1
Percent
100.0
Ceftazidime
Valid
sensitif
Frequency
1
Percent
100.0
Ciprofloxacin
Valid
resisten
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Cefmetazole
Valid
sensitif
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Ceftriaxone
Valid
sensitif
Frequency
1
Percent
100.0
Cefotaxime
Valid
sensitif
Frequency
1
Percent
100.0
ESBL
Valid
-
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Ertapenem
Valid
sensitif
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Cefepime
Valid
sensitif
Frequency
1
Percent
100.0
Gentamicin
Valid
sensitif
Frequency
1
Percent
100.0
Levofloxacin
Valid
Frequency
1
resisten
Percent
100.0
Cumulative
Percent
100.0
Valid Percent
100.0
Meropenem
Valid
sensitif
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Ampicillin/Sulbactam
Valid
intermediet
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Trimethoprim/Sulfamethoxazole
Valid
resisten
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Tigecycline
Valid
sensitif
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Piperacillin/Tazobactam
Valid
sensitif
Frequency
1
Percent
100.0
Valid Percent
100.0
Cumulative
Percent
100.0
Patient
ID
Testing Date
Organism Name
Onset
AM
Esch.coli
E
R
AMC
AMX
AN
ATM
CAZ
CIP
CRO
CTX
CZ
R
S
R
R
R
R
R
R
R
R
R
R
R
S
R
R
R
R
R
R
R
R
R
S
R
R
R
R
DOR
ESB
ETP
FEP
GM
+
S
R
+
S
IPM
LEV
MEM
SAM
SXT
TGC
TZP
R
R
S
R
S
S
I
R
R
I
R
R
R
S
R
R
R
R
S
R
R
S
I
R
R
I
R
R
R
S
R
R
S
R
S
R
R
S
R
609028
8/2/2014
610522
9/23/2014
Aci.baumannii
E
R
616020
8/15/2014
K.pneum.pneumoniae
E
R
616608
8/13/2014
Aci.baumannii
E
R
617840
8/13/2014
K.pneum.pneumoniae
E
R
595190
11/11/2014
K.pneum.pneumoniae
L
R
S
R
R
R
R
R
R
R
R
R
R
S
I
R
606159
12/1/2014
Steno.maltophilia
L
R
R
R
R
R
R
R
R
R
I
R
R
R
S
R
609469
12/30/2014
Staph.aureus
L
R
S
S
S
R
S
S
S
R
S
I
R
S
S
611338
8/6/2014
Aci.baumannii
L
R
R
R
R
R
R
R
R
I
R
R
R
S
R
611696
9/17/2014
Aci.baumannii
E
R
S
R
R
I
R
R
R
S
S
R
R
S
S
611936
9/24/2014
Aci.baumannii
E
S
S
I
S
S
S
S
S
S
S
S
S
S
S
S
618956
8/6/2014
K.pneum.pneumoniae
E
R
R
R
R
R
R
R
R
R
R
R
R
S
R
619931
10/16/2014
Esch.coli
E
R
S
R
R
R
R
R
R
R
R
R
S
S
R
622877
7/16/2014
Aci.baumannii
E
R
R
S
R
R
R
S
R
S
R
S
S
623746
10/17/2014
Esch.coli
E
R
R
S
S
R
R
S
S
S
S
S
S
624873
11/19/2014
Aci.baumannii
L
R
R
R
R
R
625344
12/2/2014
Esch.coli
E
R
R
S
S
S
S
S
628059
9/13/2014
Aci.baumannii
E
R
R
S
S
S
606356
10/2/2014
Aci.baumannii
E
R
615868
7/2/2014
K.pneum.pneumoniae
E
R
616055
11/7/2014
Aci.baumannii
E
620319
9/12/2014
Ps.aeruginosa
617163
9/13/2014
610851
R
R
R
R
R
S
R
R
R
R
R
R
R
R
S
S
S
S
S
I
I
R
R
S
R
R
I
R
R
R
R
R
R
R
L
I
R
R
R
R
R
Aci.baumannii
E
R
S
R
R
R
R
12/1/2014
Aci.baumannii
E
R
S
R
R
R
R
619455
10/22/2014
Aci.baumannii
E
R
R
R
R
R
R
611712
8/4/2014
K.pneum.pneumoniae
L
R
S
R
R
R
R
R
623582
7/4/2014
K.pneum.pneumoniae
L
R
R
R
R
S
R
R
R
R
-
R
S
R
+
S
S
R
R
R
R
S
R
R
R
+
R
S
R
S
S
R
R
R
S
S
S
S
R
S
S
S
S
R
R
R
R
R
R
S
R
R
R
S
S
R
R
S
I
R
R
R
R
R
R
S
R
R
R
R
S
I
R
S
R
R
S
R
R
S
R
S
R
R
R
R
R
R
R
R
S
R
R
R
R
R
R
R
S
R
R
R
R
S
R
R
S
I
R
S
R
+
R
-
R
+
S
S
R
S
R
S
S
ffi
PAI{DIIIIKAN
I}A1S T{T'BUNAYA AN
UI{IVERSITASSI]I\IATERA{ITARA
FAITULTAS KEDOKTfiRAN
20155
F
Jalan dr. T. Mansur No. 5 Kampus USU Medan
Telp, (061) 8211445,8210555 Fax. (061) 8216264, e-mail: dean.med@usu.ac.id
, V71 /uN5.2.1. r/sPB/2ol
No
Lamp
Hal
: Izin Penelitian
Medan, ?{Agustus 2015
5
Kepada Yth:
Direktur RS{-IP F.{aji Adann Malik Medan
di
Tempat
Dengan horrnat, berkenaan derlgan kegiatan Kryya Tulis llmiah (KTI) Mahasiswa Falrultas
Kedokteran USU Angkatan 20l2,maka karni mohon kepada Mahasiswa tersebut di bawah
ini:
NamA
NIM
JUDUL
: DASTA SENORITA GINTING
: tr20tr00251
: Pola Kepekaan Bakteri Fenyebab Ventilatory Associated Pneumonia
(VAP) di ICU RSttP H. Adam Malik Periode Juli-Desernber 2014
Dapat diberi izin Peneli,tian di Institusi yang Bapakltbu Pimpin, dalam rangka pengunrpulan
data untuk penulisan
KTI
tersebut.
''"*'
Demikian Atas bantuan dan perhatian mengenai hal ini kami ucapkan terima kasih.
N]F. 195
Tembusan:
- Pertinggal
D.Tjrpta, SpA(K)
v 198111 I 002
rqf,e*
Hft * HfirrnrffiE|r kt
ffi 3ft eH* Hffi
tL
20lE[ - lmilonsia
ll, Br. tamlur to S tdan,
Tel: +62414.21{045; 8210555 Fax: +62€14218264 E-mail:
komisieti kfkusu@ya haoo.com
PERSETUJUAII KOMISI ETIK TENTANG
PELAKSANAAIT PENELITIAI\ BIDANG KESEHATAN
Namor: 196IKOMET IFK USU /2015
Yang bertanda tangan di bawah ini, Ketua Komisi Etik Penelitian Bidang Kesehatan Fakultas
Kedokteran Universitas Sumatera Utara, setelah dilaksanakan pembahasan dan penilaian usulan
penelitian yang berjudul :
"Pola Kepekaan Bakteri Penyebab Ventilator AssociatedPneumonia {VAP)
Di ICU RSUP H. Adam Malik Periode Juli-Desember 2014',
Yang menggunakan manusia d*==+er*,m sebagai subjek penelitian dengan
Pelaksana/Peneliti Utama: Dasta Senorita
ketua
Ginting
Dari Institusi : Fakultas Kedokteran USU
Dapat disetujui pelaksanaannya selama tidak bertentangan dengan kaidah neuremberg code dan
deklarasi helsinki.
Medan, 4Q- Agustus 2015
Komisi Etik Penelitian Bidang Kesehatan
:
RSUP H.ADAl\d MALIK
DIREKTORAT SDM DAN PENDIDIKAN
INSTALASI PENELITIAN DAN PENGEMBANGAN
Jl. Bunga LauNo. 17 Medan
L8.02.03.II.4
Nomor.
"
*"*
iffitr-ffir?
Pos247 Airphone 142
lln
Medan, O( September 2015
Lampiran
Ijin Penelitian
Perihal
Yth
Kepada
:
.&.*r. ..n!M.B.e,qv^. &e*erv
rrd/;
RSUP H Adam Malik
di-
Medan
Medan
Menindaklanjuti surat pembantu Dekan I Fakultas Kedokteran Universitas Sumatera Utara
No.77gluN5.2.1.l/SpB ll2}ll,Tanggal24Agustus 2015 perihal : Ijin Penelitian, maka bersama ini
kami hadapkan peneliti/Ivlahasiswa tersebut untuk dibantu dalam pelaksanaannyavA.dapun nama
penelitiltvlahasiswa yang akan melaksanakan sebagai berikut
NaMA
:DASTASENORITAGINTING
NIM
:
Institusi
: FK-USU Medan
Judu
1
:
120100251
: Pola Kepekaan Bakteri Penyebab Ventilator Associated Pneumonia (VAP) di ICU
RSUP H. Adam Malik Medan Periode'Januari
perlu kami informasikan surat
iiin
penelitian
ini
-
Desember 2014
berlangsung paling lambat 1 (satu) bulan
terhitung sejak surat ini dikeluarkan.
Demikian kami sarnpaikan, atas perhati{lnnya diucapkan terimakasih.
Kepala Instalasi Litbang,
[A
line *diLtuti,sKM.M.Kes
NrP.197106181995
Tembusan
:
l.Ka.Bidang Diklit RSUP H Adam Malik Medan
0l
2001